Howard E. Gendelman
Howard E. Gendelman is a renowned neurologist and immunologist who has made significant contributions to the field of neurodegenerative diseases, particularly in the study of HIV-associated neurocognitive disorders (HAND). He is currently the Margaret R. Larson Professor of Internal Medicine and Infectious Diseases and Chair of the Department of Pharmacology and Experimental Neuroscience at the University of Nebraska Medical Center (UNMC).
Early Life and Education
Gendelman was born and raised in Brooklyn, New York. He completed his undergraduate studies at Rensselaer Polytechnic Institute and earned his medical degree from the Pennsylvania State University College of Medicine. He completed his residency in Internal Medicine at the Mount Sinai Hospital and a fellowship in Infectious Diseases and Immunology at the Johns Hopkins Hospital.
Career
Gendelman began his career at the National Institutes of Health (NIH), where he conducted research on HIV/AIDS. In 1992, he joined the faculty of the University of Nebraska Medical Center (UNMC), where he founded the Center for Neurovirology and Neurodegenerative Disorders (CNND). Under his leadership, the CNND has become a leading research center for neurodegenerative diseases.
Gendelman's research focuses on the pathogenesis of neurodegenerative diseases, particularly HIV-associated neurocognitive disorders (HAND). His work has led to the development of new therapeutic strategies for HAND, including the "nanoART" strategy, which involves the use of nanotechnology to deliver antiretroviral drugs to the brain.
Awards and Honors
Gendelman has received numerous awards and honors for his contributions to the field of neurology and immunology, including the Distinguished Scientist Award from the Society for Neurovirology and the J. Jacob and Louise Gershon-Cohen Memorial Award in Biomedical Sciences from the Pennsylvania State University College of Medicine.
See Also
- Neurodegenerative diseases
- HIV-associated neurocognitive disorders
- University of Nebraska Medical Center
References
<references />
External Links
- Howard E. Gendelman at the University of Nebraska Medical Center
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
